Allerfund Ventures, Llc
Venture capitalNew York · Pre-Seed–Seed
Investment thesis
AllerFund invests in early-stage companies working on promising research and technologies to improve the lives of those with food allergies. The firm supports entrepreneurs and scientists in building businesses around these innovations, providing both capital and strategic business guidance.
Source: firm website, verified Jul 21, 2026.
What they invest in
from 12 of 12 portfolio companiesHealthtech ×9Medical Devices ×6AI & Machine Learning ×4Biotech ×3FoodTech ×3Consumer ×2Digital Health ×2Direct to Consumer ×1
HQs:United States×2Belgium×1
Investments · 12 tracked
founders shown can be your intro pathAllergyamulet develops a portable food allergen and ingredient sensor to help people with food allergies safely identify potential allergens in food before consumption.
ConsumerHardwareHealthtechMedical Devices
Abigail Barnes(Co-Founder & CEO)
Anjo is an AI-powered wearable platform that monitors physiological signals from smart devices to detect early signs of allergic reactions and provide personalized insights for people with life-threatening allergies. The platform analyzes real-world data to alert parents and physicians to potential anaphylaxis before clinical symptoms emerge.
AI & Machine LearningDigital HealthHealthtech
Moonlight Therapeutics develops an intradermal stamp technology for treating food allergies, with its lead candidate MOON101 focused on peanut allergy treatment.
BiotechMedical Devices
Hippo DX develops S.P.A.T., an automated skin prick test device for allergy testing in healthcare settings. The device uses AI-assisted readout to deliver faster, more standardized, and patient-friendly allergy test results compared to manual testing.
AI & Machine LearningHealthtechMedical DevicesLiège, BE
FAST-PASE® is a blood-based allergy diagnostic test that measures mast cell activation in response to allergens, offering safer and more accurate results than traditional skin-prick or food challenge tests. The company focuses on developing diagnostics for common food allergens and other allergic conditions.
BiotechDigital HealthMedical Devices
EvoEndo develops FDA-cleared endoscopy systems that enable sedation-free transnasal and transoral procedures for patients of all ages. The company manufactures ultra-thin, flexible scopes with advanced imaging and patient distraction technology to reduce risk and improve accessibility in upper gastrointestinal diagnostics.
HealthtechMedical Devices
Fig is an app that helps users with dietary restrictions (gluten-free, food intolerances, ingredient avoidance) discover foods and products that match their dietary needs. The platform combines a personalized food fingerprint tool with product matching and community resources to support people navigating food choices.
ConsumerHealthtech
IgGenix is a clinical-stage biotechnology company focused on antibody discovery and development for allergies and immunological diseases. The company uses its proprietary SEQ SIFTER™ platform to develop first-in-class therapeutic antibodies targeting allergic cascades.
AI & Machine LearningBiotechHealthtechSouth San Francisco, US
Kari Nadeau(Scientific Co-Founder)
Latitude Food Allergy Care provides oral immunotherapy (OIT) and diagnostic testing for food allergies, serving families and individuals seeking desensitization treatment and allergy management. The practice operates multiple clinics across California and New York.
HealthtechMedical DevicesSan Rafael, US
LiberEat provides automated allergen error detection technology for food safety teams. The software scans supplier data, menus, product labels, and labeling information to identify undeclared allergens and mislabeled ingredients in real-time, alerting food safety teams before errors reach consumers.
AI & Machine LearningFoodTech
Ready Set Food produces food products designed for early allergen introduction in infants, supporting medical guidance from pediatricians and national health associations. The product line targets parents introducing common food allergens to babies as early as 4 months of age to help reduce allergy risk.
FoodTechHealthtech
YUMI makes science-backed nutrition meals and snacks for babies and toddlers using organic ingredients, with educational content tied to developmental milestones. The company targets parents seeking healthy food options designed to support early childhood brain and metabolic development.
Direct to ConsumerFoodTechHealthtech
Angela Sutherland(Co-Founder, CEO)Evelyn
Frequently asked questions
- What stage does Allerfund Ventures, Llc invest at?
- Allerfund Ventures, Llc invests at the Pre-Seed, Seed stages.
- What sectors does Allerfund Ventures, Llc focus on?
- Allerfund Ventures, Llc focuses on Biotech, FoodTech, Healthtech, Impact & Social Good.
- Where is Allerfund Ventures, Llc located?
- Allerfund Ventures, Llc is headquartered in New York, US.
Images
Similar investors
Everywhere Ventures is an early-stage venture capital firm that backs founders across all sectors and geographies. The firm invests in pre-seed and seed stage companies and is known for providing high-value support to founders through its active investor community of LPs who are themselves founders and operators.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.
Lerer Hippeau is an early-stage venture capital firm focused on identifying and backing founders before they achieve prominence. The firm actively invests across multiple sectors including AI/ML, healthtech, fintech, enterprise software, and other emerging technology areas.
Octopus Ventures is a pan-European early-stage venture capital firm that invests from pre-seed through Series A and beyond, with pre-seed investments typically at £100k and later-stage investments starting at £1 million.
